deflazacort
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
17 FDA-registered drug labelers
ALMON HEALTHCARE PRIVATE LIMITED
Amneal Pharmaceuticals NY LLC
Aucta Pharmaceuticals, Inc.
Aurobindo Pharma Limited
AvKARE
Cranbury Pharmaceuticals, LLC
Dasami Lab Private Limited
Doppel Farmaceutici S.r.l.
NEWCHEM SPA
PTC Therapeutics, Inc.
Sterling S.p.A.
Sun Pharmaceutical Industries, Inc.
Symbiotec Pharmalab Limited
Symbiotica Speciality Ingredients Sdn. Bhd.
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Upsher-Smith Laboratories, LLC
Zydus Pharmaceuticals (USA) Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 7 drug and cosmetic product listings (FDA).
- •Deflazacort Oral Suspension
- •Deflazacort
- •Jaythari
- •Jaythari Oral Suspension
- •Emflaza
- •Kymbee
- •Pyquvi
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS14484-47-0
PubChem CID189821
DTXSIDDTXSID9020378
FormulaC25H31NO6
Mol. Weight441.5 g/mol
SMILESCC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C
Data Sources
1898212026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/deflazacort/cids/JSON
Archive: data/sources/pubchem_name/deflazacort.json
CAS 14484-47-02026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json